PTC Therapeutics Director Reeve Emma Buys and Sells Shares on November 12, 2025.

PTC Therapeutics, Inc. (PTCT) has recently announced a significant transaction involving one of its directors. Reeve Emma, a member of the company's board, has made a notable purchase and sale of shares. On November 12, 2025, Emma acquired 7,333 shares at a price of $46.54 per share. However, later on the same day, she sold an identical number of shares at $74.5 per share. This transaction highlights Emma's confidence in the company's prospects and underscores the ongoing interest in PTC Therapeutics, Inc. among investors and market participants.